{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:22:05Z","timestamp":1782516125943,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.maturitas.2014.02.015","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T18:16:03Z","timestamp":1394820963000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial"],"prefix":"10.1016","volume":"78","author":[{"given":"D.","family":"Portman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.O.","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.maturitas.2014.02.015_bib0005","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis","volume":"61","author":"Bachmann","year":"2000","journal-title":"Am Fam Physician"},{"issue":"Suppl. 3","key":"10.1016\/j.maturitas.2014.02.015_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1743-6109.2005.00131.x","article-title":"Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women","volume":"2","author":"Goldstein","year":"2005","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.maturitas.2014.02.015_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.maturitas.2014.02.015_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal health: insights, views & attitudes (VIVA) \u2013 results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","article-title":"Women's voices in the menopause: results from an international survey on vaginal atrophy","volume":"67","author":"Nappi","year":"2010","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.maturitas.2014.02.015_bib0030","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J Sex Med"},{"issue":"8","key":"10.1016\/j.maturitas.2014.02.015_bib0035","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.maturitas.2014.02.015_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13697137.2013.871696","article-title":"Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause","volume":"17","author":"Nappi","year":"2014","journal-title":"Climacteric"},{"issue":"6","key":"10.1016\/j.maturitas.2014.02.015_bib0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jwh.2009.1384","article-title":"Recognizing and treating urogenital atrophy in postmenopausal women","volume":"19","author":"Goldstein","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.maturitas.2014.02.015_bib0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/gme.0b013e318182f84b","article-title":"Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach","volume":"15","author":"Ettinger","year":"2008","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.maturitas.2014.02.015_bib0065","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","year":"2013","journal-title":"Menopause: J North Am Menopause Soc"},{"key":"10.1016\/j.maturitas.2014.02.015_bib0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJWH.S41897","article-title":"Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy","volume":"5","author":"Minkin","year":"2013","journal-title":"Int J Womens Health"},{"issue":"5","key":"10.1016\/j.maturitas.2014.02.015_bib0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1701-2163(16)30662-4","article-title":"The detection and management of vaginal atrophy","volume":"26","author":"Johnston","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"10.1016\/j.maturitas.2014.02.015_bib0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13697130802585576","article-title":"Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview","volume":"12","author":"Al-Baghdadi","year":"2009","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1743-6109.2008.01198.x","article-title":"The use of estrogen therapy in women's sexual functioning (CME)","volume":"6","author":"Nappi","year":"2009","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.maturitas.2014.02.015_bib0090","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/17425255.2010.487483","article-title":"Pharmacologic evaluation of ospemifene","volume":"6","author":"McCall","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0095","first-page":"1","article-title":"Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy","volume":"21","author":"Pinkerton","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.maturitas.2014.02.015_bib0100","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/endo.141.2.7342","article-title":"Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats","volume":"141","author":"Qu","year":"2000","journal-title":"Endocrinology"},{"issue":"4\u20135","key":"10.1016\/j.maturitas.2014.02.015_bib0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(01)00066-8","article-title":"In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer","volume":"77","author":"Taras","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.maturitas.2014.02.015_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/gme.0b013e31826d36ba","article-title":"One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus","volume":"20","author":"Simon","year":"2012","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.maturitas.2013.12.005","article-title":"Long-term safety of ospemifene (52-week extension) in the treatmentof vulvar and vaginal atrophy in hysterectomized postmenopausal women","volume":"77","author":"Simon","year":"2014","journal-title":"Maturitas"},{"issue":"12\u201313","key":"10.1016\/j.maturitas.2014.02.015_bib0120","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.steroids.2013.09.003","article-title":"Tissue selectivity of ospemifene: pharmacologic profile and clinical implications","volume":"78","author":"Kangas","year":"2013","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.maturitas.2014.02.015_bib0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.02.015_bib0130","series-title":"Food and Drug Administration FDA approves Osphena for postmenopausal women experiencing pain during sex","year":"2013"},{"issue":"9715","key":"10.1016\/j.maturitas.2014.02.015_bib0135","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(09)61706-2","article-title":"Biological, clinical, and ethical advances of placebo effects","volume":"375","author":"Finniss","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.maturitas.2014.02.015_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1743-6109.2010.02007.x","article-title":"Behavior and symptom change among women treated with placebo for sexual dysfunction","volume":"8","author":"Bradford","year":"2011","journal-title":"J Sex Med"},{"issue":"4","key":"10.1016\/j.maturitas.2014.02.015_bib0145","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2007.07.1359","article-title":"Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women","volume":"90","author":"Simon","year":"2008","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.maturitas.2014.02.015_bib0150","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","article-title":"Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally","volume":"16","author":"Bachmann","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.02.015_bib0155","series-title":"The 61st Annual Clinical Meeting of The American College of Obstetricians and Gynecologists","article-title":"Overall safety and efficacy of ospemifene for vulvar and vaginal atrophy in postmenopausal women","author":"Portman","year":"2013"},{"issue":"3","key":"10.1016\/j.maturitas.2014.02.015_bib0160","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/gme.0b013e3181c4f1d6","article-title":"Endometrial safety: a key hurdle for selective estrogen receptor modulators in development","volume":"17","author":"Pinkerton","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.02.015_bib0165","article-title":"Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy","author":"Goldstein","year":"2013","journal-title":"Climacteric"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:59:32Z","timestamp":1759913972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512214000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0378512214000681"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.02.015","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}